Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Apr-24 5:48 PM View:  | Zai Lab Ltd (ZLAB) | 04-Apr-24 | Option Sale | 1,988 | $15.67 | $31,157.90 | (6%) 30.67K to 28.68K | |
| 05-Apr-24 5:48 PM View: | Zai Lab Ltd (ZLAB) | 03-Apr-24 | Option Exercise | 7,145 | $15.90 | $113,606.00 | 30% 23.53K to 30.67K | |
| 04-Mar-24 4:28 PM View: | Zai Lab Ltd (ZLAB) | 01-Mar-24 | Private Purchase (Planned) | 3,000 | $20.83 | $62,490.00 | 15% 20.53K to 23.53K | |
| 18-Dec-23 5:08 PM View: | Zai Lab Ltd (ZLAB) | 14-Dec-23 | Private Purchase (Planned) | 4,000 | $29.90 | $119,600.00 | 24% 16.53K to 20.53K | |
| 16-Nov-23 6:04 PM View: | Zai Lab Ltd (ZLAB) | 16-Nov-23 | Private Purchase (Planned) | 5,000 | $26.93 | $134,650.00 | 43% 11.53K to 16.53K | |
| 17-Aug-23 5:36 PM View: | Zai Lab Ltd (ZLAB) | 15-Aug-23 | Payment of Exercise | 4,373 | $24.52 | $107,226.00 | (28%) 15.9K to 11.53K | |
| 17-Aug-23 5:36 PM View: | Zai Lab Ltd (ZLAB) | 15-Aug-23 | Option Exercise | 15,900 | -- | -- | 100% 0 to 15.9K | |
| 10-Feb-21 8:46 PM View: | Eli Lilly & Co. (LLY) | 08-Feb-21 | Grant | 25,409 | $205.77 | $5,228,410.00 | 47% 54.4K to 79.81K | (2%) |
| 03-Feb-21 8:22 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-21 | Payment of Exercise | 8,452 | $207.97 | $1,757,760.00 | (13%) 62.85K to 54.4K | |
| 03-Feb-21 8:22 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-21 | Option Exercise | 19,266 | -- | -- | 44% 43.59K to 62.85K | |
| 05-Oct-20 12:19 PM View: | Eli Lilly & Co. (LLY) | 01-Oct-20 | Payment of Exercise | 3,482 | $148.02 | $515,406.00 | (7%) 47.05K to 43.57K | (12%) |
| 05-Oct-20 12:19 PM View: | Eli Lilly & Co. (LLY) | 01-Oct-20 | Option Exercise | 7,947 | -- | -- | 20% 39.1K to 47.05K | |
| 13-Feb-20 6:17 PM View: | Eli Lilly & Co. (LLY) | 11-Feb-20 | Grant | 5,447 | $144.25 | $785,730.00 | 16% 33.58K to 39.03K | 13% |
| 28-Oct-19 3:06 PM View: | Eli Lilly & Co. (LLY) | 25-Oct-19 | Market Purchase | 929 | $107.59 | $99,951.10 | 3% 32.62K to 33.55K | 51% |
| 15-Jul-19 3:46 PM View: | Eli Lilly & Co. (LLY) | 15-Jul-19 | Market Purchase (Planned) | 185 | $108.47 | $20,067.00 | < 1% 32.43K to 32.61K | 49% |
| 05-Jun-19 2:15 PM View: | Eli Lilly & Co. (LLY) | 05-Jun-19 | Market Purchase | 426 | $118.03 | $50,280.80 | 1% 32.0K to 32.43K | 37% |
| 06-Feb-19 8:02 PM View: | Eli Lilly & Co. (LLY) | 04-Feb-19 | Grant | 9,954 | $120.17 | $1,196,170.00 | 45% 21.98K to 31.93K | 36% |
| 20-Mar-18 12:06 PM View: | Eli Lilly & Co. (LLY) | 16-Mar-18 | Market Sale (Planned) | 3,000 | $79.20 | $237,600.00 | (12%) 24.89K to 21.89K | (103%) |
| 31-Jan-18 6:10 PM View: | Eli Lilly & Co. (LLY) | 29-Jan-18 | Grant | 7,202 | $87.60 | $630,895.00 | 41% 17.61K to 24.81K | 82% |